Enhanced recovery from fulminant myocarditis by treatment with the combined use of the Impella left ventricular assist device with extracorporeal membrane oxygenation: a case series
Open Access
- 27 February 2022
- journal article
- case report
- Published by Springer Nature in JA Clinical Reports
- Vol. 8 (1) , 1-5
Abstract
We experienced two adult cases of fulminant myocarditis with severe cardiogenic shock where Impella left ventricular assist device [left ventricle (LV)-Impella] was concomitantly used with venoarterial extracorporeal membrane oxygenation (V-A ECMO). A 67-year-old man and a 49-year-old man with fulminant myocarditis were transferred to our hospital with mechanical support of V-A ECMO and IABP. Impella 5.0 and Impella CP were implanted 21 h and 17 h after establishing V-A ECMO for each case. Within 1 week, the patients’ LV function progressively improved. Then the Impellas were withdrawn after discontinuing V-A ECMO. They were discharged from the intensive care unit within the following 8 days. The optimal introducing timing of LV-Impella is not currently precise. However, this case report suggests that the initiation of LV-Impella within at least 24 h after establishing V-A ECMO may be acceptable for the recovery of cardiac function.Keywords
This publication has 13 references indexed in Scilit:
- The Clinical Potential of Impella 5.0 Support in the Treatment of Recurrent Fulminant Viral Myocarditis with Profound Cardiogenic ShockInternal Medicine, 2019
- The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD RegistryJournal of Cardiac Failure, 2018
- Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA ConceptsJournal of Cardiovascular Translational Research, 2018
- Fulminant Myocarditis Managed by Extracorporeal Life Support (Impella® CP): A Rare CaseCase Reports in Cardiology, 2017
- Concomitant Implantation of Impella® on Top of Veno-Arterial Extracorporeal Membrane Oxygenation May Improve Survival of Patients with Cardiogenic ShockEuropean Journal of Heart Failure, 2016
- Venoarterial Extracorporeal Membrane Oxygenation for Acute Fulminant Myocarditis in Adult Patients: A 5-Year Multi-Institutional ExperienceThe Annals of Thoracic Surgery, 2016
- Use of the Impella 5.0 Device as a Bridge to Recovery in Adult Fulminant Viral MyocarditisInnovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2015
- Novel Combination of Impella and Extra Corporeal Membrane Oxygenation as a Bridge to Full Recovery in Fulminant MyocarditisCase Reports in Critical Care, 2012
- Combined Use of Impella Left Ventricular Assist Device and Extracorporeal Membrane Oxygenation as a Bridge to Recovery in Fulminant MyocarditisASAIO Journal, 2012
- Update on MyocarditisJACC, 2012